ReviewEcancermedicalscience2018

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy.

Nigel P Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.